Beacon Cancer Center PLLC

Coeur d'Alene, Idaho 83814

0 studies enrolling now · 1 studies all time

What they study most

Bladder Cancer, Chemotherapy-induced Neutropenia, Metastatic Bladder Cancer, Myelosuppression Adult, Urothelial Carcinoma

Studies at this site

• Trilaciclib, a CDK 4/6 Inhibitor, in Patients With Advanced/Metastatic Bladder Cancer Receiving Chemotherapy Then Avelumab — Stopped early